2023
DOI: 10.1016/j.bjane.2023.07.004
|View full text |Cite
|
Sign up to set email alerts
|

Hydroxyethyl starch for perioperative fluid management: a critical appraisal

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(4 citation statements)
references
References 14 publications
(17 reference statements)
0
4
0
Order By: Relevance
“…Wei et al [17] reported evidence of increased blood loss in 216 patients receiving HA compared to 222 patients receiving HES during cardiac surgery, without an increase in transfusion requirements. Increased bleeding in the HA group compared with the HES group in adult cardiac surgery contradicts previous meta-analytic evidence [39] and may be prone to bias [26]. The use of HES has recently been severely restricted owing to safety concerns [32].…”
Section: Discussionmentioning
confidence: 86%
See 3 more Smart Citations
“…Wei et al [17] reported evidence of increased blood loss in 216 patients receiving HA compared to 222 patients receiving HES during cardiac surgery, without an increase in transfusion requirements. Increased bleeding in the HA group compared with the HES group in adult cardiac surgery contradicts previous meta-analytic evidence [39] and may be prone to bias [26]. The use of HES has recently been severely restricted owing to safety concerns [32].…”
Section: Discussionmentioning
confidence: 86%
“…The analysis showed no differences in mortality or total infusion between the two groups. However, given the safety concerns and the changing approval status of HES globally [ 26 ], the results of this study are likely to be secondary.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations